Stock Screener App

Gratuito -

Installare

3.755

2.71% -0.125

Larimar Therapeutics Inc (LRMR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	10.89% 27.79	31.19	31.29	18.26	24.60
Operating Income/Loss	10.89% -27.79	-31.19	-31.29	-18.26	-24.60
Nonoperating Income/Loss	15.57% 1.61	1.907	2.469	2.765	2.972
Income/Loss From Continuing Operations Before Tax	10.58% -26.18	-29.28	-28.82	-15.50	-21.63
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	10.58% -26.18	-29.28	-28.82	-15.50	-21.63
Net Income/Loss	10.58% -26.18	-29.28	-28.82	-15.50	-21.63
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.10% 64.03	63.96	0.8564	63.81	63.80
Diluted Average Shares	0.10% 64.03	63.96	0.8564	63.81	63.80
Basic Earnings Per Share	10.87% -0.41	-0.46	-0.46	-0.24	-0.34
Diluted Earnings Per Share	10.87% -0.41	-0.46	-0.46	-0.24	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.88

1.49%

GMAB

$29.28

1.93%

INCY

$103.10

1.51%

BNTX

$104.49

0.38%

ONC

$315.07

1.04%

INSM

$185.94

0.29%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters